A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
PRT-201 is a protein that causes long lasting dilation of blood vessels when applied to the
outside surface of the blood vessel. The purpose of this study is to determine if PRT-201,
when applied to a limited segment of blood vessel immediately after surgery to create an
arteriovenous fistula (AVF), is safe, dilates the blood vessel, and increases blood flow
through the AVF.